The Efficacy of Palbociclib-Conjugated ZnO-Ordered MesoporousCarbon Nanohybrid against MCF-7 Breast Cancer Cell Line

20260 citationsJournal Article

Authors

All findings demonstrated that the designed Pal@ZnO-OMC hybrid can be a potent nanoformulation for the treatment of MCF-7 breast cancer.

Good health and well-being

Published in: Current Medicinal Chemistry

Volume 33

Field-Weighted Citation Impact: 0.00